Cardisio offers a non-invasive cardiac screening solution called Cardisiographie, which utilizes artificial intelligence to analyze electrocardiogram (ECG) data for early detection of coronary and structural heart diseases. This technology enables healthcare providers to identify potential heart issues within minutes, significantly improving patient outcomes by facilitating timely intervention before symptoms arise.
Funding
$4.1M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Traditional methods of cardiac screening, such as stress ECGs, often fail to detect early signs of coronary and structural heart diseases, leading to delayed intervention and potentially poorer patient outcomes. Current diagnostic pathways may also involve invasive procedures or expose patients to radiation, creating additional risks and costs.
Solution
Cardisio offers Cardisiographie (CSG), a non-invasive cardiac screening solution that uses artificial intelligence to analyze electrocardiogram (ECG) data for the early detection of heart conditions. The technology captures a four-minute signal using five electrodes, similar to a standard ECG, and transmits the data to Cardisio's server. A proprietary AI algorithm processes the parameters in approximately five minutes, generating a comprehensive report that aids in identifying potential structural heart diseases, arrhythmias, and coronary artery disease (CAD) risks before symptoms manifest. This enables healthcare providers to proactively manage patient care, potentially preventing severe disease progression and facilitating timely treatment adjustments.
Target Audience
The primary target audience includes general practitioners, cardiologists, and other healthcare providers seeking a quick, non-invasive method for early cardiac risk assessment in patients with undefined symptoms or as part of routine check-ups.
Features
- AI-powered analysis of ECG data for early detection of cardiac issues
- Non-invasive procedure using only five electrodes
- Rapid results within five minutes of signal capture
- Detection of risks before symptoms appear
- Identification of structural heart diseases, arrhythmias, and coronary artery disease (CAD)
- Integration into regular medical check-ups and pre-anesthesia evaluations
- Cloud-based report generation and secure data transmission